D&I webinar – Avoin lähdekoodi, tekoäly ja IPR:t

D&I Webinar

Event date

14 May

2024

Dittmar & Indrenius > Insight > D&I webinar – Avoin lähdekoodi, tekoäly ja IPR:t

Webinaari tiistaina 14.5.2024 klo 9.00 – 10.00

Toukokuussa Partner Anna Haapanen ja Associate Petro Vornanen tarjoavat katsauksen avoimen lähdekoodin käyttöön tekoälyn opetusdatana ja siihen liittyviin monipuolisiin IPR-kysymyksiin. Vieraspuhujana webinaarissa on Ossi Raita, Director, Nokia Legal and Compliance. Webinaarissa perehdytään muun muassa seuraaviin teemoihin:

  • Avoimen lähdekoodin IPR-suoja ja lisenssit tekoälyn kontekstissa
  • Kolmansien osapuolten IPR:ien loukkausriski ja sen hallinta
  • Generatiivisen tekoälyn avulla luodun lähdekoodin IPR-suoja (tai sen puute)
  • Avoimeen lähdekoodiin, generatiiviseen tekoälyyn ja sen avulla luotuun aineistoon liittyvät IPR-oikeustapaukset

Jos et ole saanut kutsua ja haluaisit osallistua webinaareihin, voit olla yhteydessä: [email protected].

More by the same author

Implementing the Data Act without Clashing with the GDPR?

The Data Act will largely apply as of 12 September 2025, imposing new obligations and rights in relation to personal and non-personal data in the context of, e.g., connected products and related services. As rules governing data expand, it is increasingly important to map what data sets are processed by an organisation and how they are managed in the upcoming regulatory framework. For data sets including personal data (which is often the case!), it is vital to align the implementation of the Data Act with existing GDPR compliance.

The Big 5 – Status of National Preparation in Finland

The so-called Big 5 acts – the Data Governance Act, Digital Markets Act, Digital Services Act, Data Act, and Artificial Intelligence Act – have been a key part of the European Data Strategy in recent years. Once approved, the Big 5 acts are directly applicable throughout the EU, but many of them require Member States to enact legislation to support their enforcement and supervision, e.g., to designate nationally competent authorities and assign them new powers.

Examining Off-label Medicine Use in Paediatric Healthcare

Our life science experts Dr Juli Mansnérus, Charlotta Bonsdorff and Petro Vornanen seized the opportunity to contribute to the intricate field of medical law as they provided their expertise to the Office of the Ombudsman for Children in the form of an article regarding off-label medicine use in children.

Latest insights

Draft New Act Governing Offshore Wind Power within the Finnish EEZ Published for Comments

Alert / 28 May 2024
Reading time 2 minutes

Government proposal regarding the implementation of EU’s NIS 2 Directive published

Alert / 24 May 2024
Reading time 2 minutes